Search Results for “” – Page 45 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes

598 Publications found

Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.

b

Oncotarget

April 26, 2016

p Cancer

c Change patient management Clinical outcomes Observational
Impact of molecular profiling on overall survival of patients with advanced ovarian cancer.

b

Oncotarget

April 12, 2016

p Cancer

c Change patient management Clinical outcomes Observational
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).

b

Lancet (London, England)

April 2, 2016

p Cancer

c Change patient management Clinical outcomes Observational
Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus.

b

Clinical nutrition (Edinburgh, Scotland)

April 1, 2016

p Diabetes

c Change patient management Clinical outcomes Meta-analysis Observational Operational efficiencies
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.

b

Gynecologic oncology

April 1, 2016

p Cancer

c Change patient management Clinical outcomes Observational
Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome.

b

The American journal of medicine

March 1, 2016

p Cardiovascular Disease

c Clinical outcomes Operational efficiencies RCT
Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations – A Systematic Review and Meta-analysis.

b

Heart, lung & circulation

March 1, 2016

p Cardiovascular Disease

c Clinical outcomes Meta-analysis Review
Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial.

b

Heart rhythm

February 1, 2016

p Cardiovascular Disease

c Clinical outcomes RCT
Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.

b

Clinics and research in hepatology and gastroenterology

February 1, 2016

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.

b

The lancet. Diabetes & endocrinology

January 1, 2016

p Diabetes

c Change patient management Clinical outcomes Observational Operational efficiencies